Palatin Technologies Inc. (PTN)

Trade PTN now with
2/19/2020 7:31:14 AM Palatin Technologies Announces First Patient Enrolled In Dry Eye Disease Phase 2 Clinical Trial With PL9643
2/11/2020 7:33:36 AM Palatin Technologies Q2 Net Loss $5.2 Mln Or $0.02/Shr Vs Net Loss $5.0 Mln Or $0.02/Shr Last Year
1/21/2020 7:32:14 AM Palatin Technologies Sees Dry Eye Disease Phase 2 Study To Commence Q1 2020 With Data In Q4 2020
11/13/2019 7:32:19 AM Palatin Technologies Q1 Net Loss $4.5 Mln Vs. Net Loss $5.7 Mln Last Year
10/17/2019 7:03:32 AM Palatin Presents On Pl8177 Oral Colon Delivery Formulation For Ulcerative Colitis
9/12/2019 7:32:26 AM Palatin Technologies Q4 Net Income Of $52.2 Mln Or $0.23/shr Vs. $11.8 Mln Or $0.06/shr Prior Year
7/1/2019 7:01:43 AM Palatin Technologies Provides Mid-Calendar Year Corporate Update
6/6/2019 7:32:42 AM Palatin Technologies: FDA Grants Orphan Drug Designation For PL-8177 For Non-infectious Chronic Anterior Uveitis
5/9/2019 7:33:41 AM Palatin Technologies Q3 Net Loss Of $5.7 Mln Or $0.03/Shr Vs Loss Of $0.7 Mln Or Breakeven Per Share Last Year